Structure-activity and structure-property relationships of novel Nrf2 activators with a 1,2,4-oxadiazole core and their therapeutic effects on acetaminophen (APAP)-induced acute liver injury

Eur J Med Chem. 2018 Sep 5:157:1376-1394. doi: 10.1016/j.ejmech.2018.08.071. Epub 2018 Aug 28.

Abstract

The antioxidant function induced by Nrf2 protects the liver from damage. We found a novel Nrf2 activator named compound 25 via structural modification of compound 1 we previously reported. In vitro, compound 25 induced Nrf2 transport into the nucleus and protected hepatocyte L02 cells from APAP-induced cytotoxicity via activating the Nrf2-ARE signaling pathway. In vivo, 25 exhibited therapeutic effects in a mouse model of acute liver injury induced by acetaminophen (APAP) by up-regulating Nrf2-dependent antioxidases and down-regulating liver injury markers in serum. Together, these results indicated that 25 is a potent Nrf2/ARE activator both in vitro and in vivo. The drug-like properties of compound 25 further revealed its potential for development as a therapeutic drug against acute liver injury.

Keywords: Acute liver injury; Antioxidant function; Nrf2 activators; Oxadiazole core; Structure-activity relationship.

MeSH terms

  • Acetaminophen
  • Cell Line
  • Chemical and Drug Induced Liver Injury / drug therapy*
  • Dose-Response Relationship, Drug
  • Humans
  • Molecular Structure
  • NF-E2-Related Factor 2 / metabolism*
  • Oxadiazoles / chemical synthesis
  • Oxadiazoles / chemistry
  • Oxadiazoles / pharmacology*
  • Structure-Activity Relationship

Substances

  • NF-E2-Related Factor 2
  • Oxadiazoles
  • Acetaminophen